These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28240527)

  • 1. Lack of any Association between the Hogg1 Ser326Cys Polymorphism and Breast Cancer Risk: a Systematic Review And Meta-Analysis Of 18 Studies.
    Kamali M; Kargar S; Heiranizadeh N; Zare M; Kargar Sh; Zare Shehneh M; Neamatzadeh H
    Asian Pac J Cancer Prev; 2017 Jan; 18(1):245-251. PubMed ID: 28240527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of hOGG1 Ser326Cys polymorphism with susceptibility to hepatocellular carcinoma.
    Guo J; Yang J; Li Y
    Int J Clin Exp Med; 2015; 8(6):8977-85. PubMed ID: 26309550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
    Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
    Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
    Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P
    PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOGG1 Ser326Cys polymorphism and susceptibility to head and neck cancer: a meta-analysis.
    Liu J; Cao XL; Zhang Z; Lei DP; Jin T; Yu XM; Pan XL
    Asian Pac J Cancer Prev; 2011; 12(10):2491-4. PubMed ID: 22320944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
    Xu Z; Yu L; Zhang X
    Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis.
    Wenjuan C; Jianzhong L; Chong L; Yanjun G; Keqing L; Hanzhang W; Zhiping W
    Int Braz J Urol; 2016; 42(5):883-896. PubMed ID: 27583352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the hOGG1 Ser326Cys polymorphism with gynecologic cancer susceptibility: a meta-analysis.
    Shi Y; Xu W; Zhang X
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33210702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between the hOGG1 1245C>G (rs1052133) Polymorphism and Susceptibility to Colorectal Cancer: a Meta-analysis Based on 7010 Cases and 10,674 Controls.
    Ghelmani Y; Asadian F; Antikchi MH; Dastgheib SA; Shaker SH; Jafari-Nedooshan J; Neamatzadeh H
    J Gastrointest Cancer; 2021 Jun; 52(2):389-398. PubMed ID: 33025423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma.
    Zhang J; Zhou J; Zhang P; Wang W; Tao S; Wang M
    PLoS One; 2013; 8(6):e65742. PubMed ID: 23762419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
    Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
    Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human 8-oxoguanine DNA glycosylase gene polymorphism (Ser326Cys) and cancer risk: updated meta-analysis.
    Kang SW; Kim SK; Park HJ; Chung JH; Ban JY
    Oncotarget; 2017 Jul; 8(27):44761-44775. PubMed ID: 28415770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hOGG1 polymorphism rs1052133 and gastric cancer.
    Zhang D; Guo X; Hu J; Zeng G; Huang M; Qi D; Gong B
    Oncotarget; 2017 May; 8(21):34321-34329. PubMed ID: 28415729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
    Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
    Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.
    Ji C; Liu Z; Chen H; Guo H; Liu C
    BMC Cancer; 2012 Aug; 12():335. PubMed ID: 22857644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and hOGG1 Ser326Cys polymorphism contribute to lung cancer risk: evidence from a meta-analysis.
    Yin ZB; Hua RX; Li JH; Sun C; Zhu JH; Su X; Ji C; Xiang Q; Hua ZM
    Tumour Biol; 2014 Feb; 35(2):1609-18. PubMed ID: 24085357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case-control studies.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Tumour Biol; 2015 Feb; 36(2):1029-38. PubMed ID: 25323581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hOGG1 Ser326Cys polymorphism and esophageal cancer risk: a meta-analysis of 1,875 cancer cases and 3,041 controls.
    Zhao C; Yang J; Xu L
    Ann Transl Med; 2019 Sep; 7(18):438. PubMed ID: 31700874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer risk.
    Park HW; Kim IJ; Kang HC; Jang SG; Ahn SA; Lee JS; Shin HR; Park JG
    J Epidemiol; 2007 Sep; 17(5):156-60. PubMed ID: 17827862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among East Asians: a meta-analysis.
    Wang W; Dang S; Li Y; Sun M; Jia X; Wang R; Liu J
    PLoS One; 2013; 8(4):e60178. PubMed ID: 23577090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.